期刊文献+

过表达转移抑制基因KAI1对乳腺癌MDA-MB-231细胞上皮间质转化的影响 被引量:2

Effect of non-metastatic gene KAI1 overexpression on epithelial-mesenchymal transition in breast cancer cell line MDA-MB-231
原文传递
导出
摘要 目的探讨过表达转移抑制基因KAI1对人乳腺癌MDA-MB-231细胞上皮间质转化的影响。方法利用慢病毒感染乳腺癌MDA-MB-231细胞,获得稳定过表达KAI1的细胞系(过表达KAI1组),并设置空白慢病毒感染的阴性对照细胞系(阴性对照组)及未处理的人乳腺癌MDA-MB-231细胞为空白对照组。用Western blot法检测KAI1蛋白过表达的情况;采用RT-PCR法检测过表达KAI1对MDA-MB-231细胞间质标志物(波形蛋白、N-钙黏蛋白和纤粘蛋白)的mRNA表达水平的影响;并用Western blot检测过表达KAI1对MDA-MB-231细胞间质标志物(波形蛋白、N-钙黏蛋白)的蛋白表达水平的影响;采用明胶酶谱检测过表达KAI1对MDA-MB-231细胞基质金属蛋白酶2(MMP2)和MMP9活性的影响。多样本均数若满足方差齐性采用单因素方差分析,其两两比较采用LSD法进行,若不满足方差齐性则采用Dunnett's T3。结果慢病毒感染MDA-MB-231细胞后,各组间AKI1蛋白表达有差异有统计学意义(F=25.610,P=0.001),并且与阴性对照组(0.575±0.065)和空白对照组(0.458±0.0500)相比,过表达KAI1组(0.953±0.034)的KAI1蛋白表达水平明显提高(P均<0.050)。RT-PCR检测表明,细胞间质标志物波形蛋白(F=10.268,P=0.012)、N-钙黏蛋白(F=32.159,P=0.001)和纤粘蛋白的mRNA(F=38.364,P=0.000)在各组间表达有差异。与阴性对照组(0.937±0.102,0.998±0.064,1.093±0.083)和空白对照组(1.000±0.000,1.000±0.000,1.000±0.000)相比,过表达KAI1组(0.636±0.027,0.576±0.038,0.435±0.051)的波形蛋白、N-钙黏蛋白和纤粘蛋白mRNA表达水平明显降低(P均<0.050),且Western blot检测表明,各组间N-钙黏蛋白(F=9.172,P=0.015)和波形蛋白(F=14.441,P=0.005)表达有差异,与阴性对照组(1.068±0.032)和空白对照组(0.957±0.103)相比,过表达KAI1组(0.597±0.032)的波形蛋白表达水平明显降低(P均<0.050);与阴性对照组(1.452±0.036)和空白对照组(1.403±0.073)相比,过表达KAI1组(1.100±0.073)的N-钙黏蛋白表达水平相似(P=0.080,0.067)。酶活性分析发现,各组间MMP2(F=18.928,P=0.003)和MMP9(F=21.310,P=0.002)表达差异有统计学意义,与阴性对照组(1.090±0.160,1.091±0.107)和空白对照组(1.000±0.000,1.000±0.000)相比,过表达KAI1组(0.326±0.047,0.460±0.071)的MMP2和MMP9表达水平明显降低(P均<0.050)。结论过表达转移抑制基因KAI1能抑制人乳腺癌MDA-MB-231细胞的间质表型。 Objective To investigate the impact of overexpression of non-metastatic gene KAI1 on the epithelial-mesenchymal transition in human breast cancer cell line MDA-MB-231. Methods Lentivirus vector was transfected into MDA-MB-231 cells to obtain the KAI1-overexpressed cell line ( KAI1 overexpression group) . The cell line with blank lentivirus vector infection served as negative control group and untreated cell line as control group. Western blot analysis was used to verify KAI1 protein expression. RT-PCR was used to detect the mRNA expression levels of vimentin, N-cadherin and fibronectin in KAI1-overexpressed MDA-MB-231 cells. Western blot was used to detect the protein expression levels of vimentin and N-cadherin. The gelatin zymography was used to detect MMP2 and MMP9 activities. If the means of multi-sample met the homogeneity of variance, ANOVA was used, otherwise Dunnett’s T3 test was used. Pairwise comparison was performed using LSD method. Results After lentivirus infection of MDA-MB-231 cells, KAI1 protein expression showed a significant difference among groups (F=25. 610, P=0. 001). Compared with the negative control group (0. 575 ± 0. 065) and control group (0. 458 ± 0. 0500), KAI1 protein level (0. 953±0. 034)was significantly higher in KAI1 overexpression group ( all P values 〈0. 050 ) . RT-PCR showed that there were significant differences in the mRNA levels of stromal cells markers vimentin (F=10. 268, P=0. 012), N-cadherin (F=32. 159, P=0. 001) and fibronectin (F=38. 364, P=0. 000) among groups. The mRNA levels of vimentin, N-cadherin and fibronectin in KAI1 overexpression group ( 0. 636 ± 0. 027, 0. 576 ± 0. 038, 0. 435 ± 0. 051 ) were significantly lower than those in negative control group (0. 937 ± 0. 102,0. 998 ± 0. 064,1. 093 ± 0. 083) and control group (1. 000 ± 0. 000,1. 000 ± 0. 000,1. 000 ± 0. 000) respectively (all P values〈0. 050). Western blot analysis showed a significant difference in protein levels of N-cadherin ( F=9. 172, P=0. 015 ) and vimentin (F=14. 441, P=0. 005) among groups. Compared with the negative control group (1. 068 ± 0. 032) and control group ( 0. 957± 0. 103 ) , vimentin protein expression in KAI1 overexpression group ( 0. 597 ± 0. 032) was significantly lower (all P values 〈0. 050), while N-cadherin expression showed no significant difference (1. 452 ± 0. 036 vs 1. 403 ± 0. 073 vs 1. 100 ± 0. 073, P=0. 080, 0. 067). The gelatin zymography showed a significant difference in the expressions of MMP2 (F=18. 928, P=0. 003) and MMP9 (F=21. 310, P=0. 002) among the groups. Compared with the negative control group (1. 090 ± 0. 160, 1. 091 ± 0. 107) and control group ( 1. 000 ± 0. 000, 1. 000 ± 0. 000 ), MMP2 and MMP9 expression levels in KAI1 overexpression group (0. 326 ± 0. 047,0. 460 ± 0. 071) were significantly lower (all P values 〈0. 050). Conclusion The overexpression of KAI1 can inhibit the mesenchymal phenotype in human breast cancer cell line MDA-MB-231.
作者 鞠涛 金志强
出处 《中华乳腺病杂志(电子版)》 CAS CSCD 2015年第4期252-256,共5页 Chinese Journal of Breast Disease(Electronic Edition)
关键词 乳腺肿瘤 癌基因 基因 肿瘤抑制 细胞系 转化 Breast neoplasms Oncogenes Genes,tumor suppressor Cell line,transformed
  • 相关文献

参考文献16

  • 1Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
  • 2Dong JT,Suzuki H,Pin SS,et al.Down-regulation of the KAIl metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss[J].Cancer Res,1996,56(19):4387-4390.
  • 3Yang X,Welch DR,Phillips KK,et al.KAIl,a putative marker for metastatic potential in human breast cancer[J].Cancer Lett,1997,119(2):149-155.
  • 4杜兴龙,汪庚明,徐洪波,江浩,承泽龙.KAI1/CD82 mRNA和蛋白在鼻咽癌组织中的表达及意义[J].临床肿瘤学杂志,2013,18(10):887-892. 被引量:1
  • 5Shiwu WU,Lan Y,Wenqing S,et al.Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer[J].Arch Iran Med,2012,15(11):707-712.
  • 6Malik FA,Sanders AJ,Kayani MA,et al.Effect of expressional alteration of KAIl on breast cancer cell growth,adhesion,migration and invasion[J].Cancer Genomics Proteomics,2009,6(4):205-213.
  • 7Yang X,Wei LL,Tang C,et al.Overexpression of KAIl suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells[J].Cancer Res,2001,61(13):5284-5288.
  • 8杨文君,陈丽荣.上皮间质转化在肿瘤侵袭转移中的作用[J].实用肿瘤杂志,2008,23(1):86-90. 被引量:10
  • 9Liu WM,Zhang XA.KAIl/CD82,a tumor metastasis suppressor[J].Cancer Lett,2006,240(2):183-194.
  • 10Abe M,Sugiura T,Takahashi M,et al.A novel function of CD82/KAI1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells[J].Cancer Lett,2008,266(2):163-170.

二级参考文献30

  • 1Hua-chuanZheng,Meng-chunWang,Jin-yiLi,Xue-feiYang,Jin-minSun,YanXin.EXPRESSION OF MASPIN AND KAI1 AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE IN CARCINOGENESIS AND PROGRESSION OF GASTRIC CANCER[J].Chinese Medical Sciences Journal,2004,19(3):193-198. 被引量:30
  • 2路丹,王文秀,徐玉清,姜秋颖,杨宇.KAI1基因对乳腺癌细胞体外增殖的抑制作用[J].中华肿瘤杂志,2007,29(8):580-583. 被引量:2
  • 3Nawshad A,Lagamha D,Polad A,et al. Transforming growth factor-β signaling during epithelial- mesenchymal transforation : Implication for emhryogenesis and tumor metastasis [J]. Cells Tissues Organs, 2005,179 (1) : 11 - 23.
  • 4Thiery JP. Epithelial-mesenchymal transitions in tumor progression [J]. Nat Rev Cancer, 2002, 2(6): 442-454.
  • 5Matsumura T,Makino R,Mitamura K,et al. Frequent down-regulation of E-cadeherin by genetic and epigenetic changes in the malignant progress of hepatocellular carcinomas [J]. Clin Cancer Res, 2001, 7(3) :594-599.
  • 6Eger A, Stockinger A,Schaffhauser B, et al. Epithelial mesenchymal transition by c-los estrogen receptor activation involves nuclear translocation of β-catenin and upregulation of β-catenin/lymphoid enhancer binding factor-1 transcriptional activity [J]. Cell Biol, 2000,148 (1) : 173-188.
  • 7Kotoh M. Epithelial-mesenchymal transition in gastric cancer [J]. Int J Oncol, 2005,27 (6) : 1677-1683.
  • 8Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail,sipl,and twist in gastric cancer [J]. AMJ Pathol, 2002,161 (5) : 1881 - 1891.
  • 9Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA dependent mechanism [J]. Mol Biol Cell, 2001,12 (1) : 27-36.
  • 10Nakajima S, Doi R, Toyoda E, et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma [J]. Clin Cancer Res, 2004, 10 (12) : 4125-4133.

共引文献9

同被引文献22

  • 1Forouzanfar MH, Foreman KJ, Delossantos AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis [J]. Lancet, 2011, 378 (9801): 1461-1484.
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics [ J]. CA Cancer J Clin, 2013, 63 (1) :11-30.
  • 3Parker JS, Mullins M, Cheang MC, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes [ J ]. J Clin Oncol, 2009, 27 (8): 1160-1167.
  • 4Watanabe H, Nonoguchi K, Sakurai T, et al. A novel protein Depp, which is induced by progesterone in human endometrial stromal cells activates Elk-1 transcription factor [ J ]. Mol Hum Reprod, 2005, 11 (7) : 471-476.
  • 5Kuroda Y, Kuriyama H, Kihara S, et al. Insulin-mediated regulation of decidual protein induced by progesterone (DEPP) in adipose tissue and liver [J]. Horm Metab Res, 2010, 42(3) : 173-177.
  • 6Shin D, Anderson DJ. Isolation of arterial-specific genes by subtractive hybridization reveals molecular heterogeneity among arterial endothelial ceils [J]. Dev Dyn, 2005, 233 (4) : 1589-1604.
  • 7Ragel BT, Couldwell WT, Gillespie DL, et al. Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis [J]. Neurosurg Rev, 2007, 30 (3) : 181-187.
  • 8Chen S, Gal J, Wang Y, et al. FoxO regulates expression of decidual protein induced by progesterone (DEPP) in human endothelial cells [J]. FEBS Lett, 2011,585(12):1796-800.
  • 9Salcher S, Hagenbuchner J, Geiger K, et al. C10ORF10/DEPP, a transcriptional target of FOX03, regulates ROS-sensitivity in human neuroblastoma[J]. Mol Cancer, 2014, 13: 224.
  • 10Deng J, Dong Y, Li C, et al. Decreased expression of C10orfl0 and its prognostic significance in human breast cancer [ J ]. PLoS One, 2014, 9(6) : e99730.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部